Permanence Bio
San Francisco, United States · Founded 2024 · $35.0M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- permanence.bio
- Total Funding
- $35.0M
- Last Round
- $20.0M Series AJan 2026
- Rounds
- 2
About
Developing therapeutics to stop mutations to prevent cancer
Summary
Permanence Bio is a Biotech company based in San Francisco, United States, founded in 2024. It has raised $35.0M in total across 2 rounds, most recently a $20.0M Series A round in Jan 2026. Investors include Permanent Capital, Shiv Chaudhary and NFX.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...